08 Jul GSK DHCPL – Risk of DRESS associated with use of aciclovir and valaciclovir-containing medicines
Posted at 13:29h
in
GlaxoSmithKline (GSK) South Africa, in collaboration with SAHPRA, would like to inform healthcare professionals about the risk of drug reaction with eosinophilia and systemic symptoms (DRESS) associated with the use of aciclovir and valaciclovir-containing medicines.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
08/07/2024
File Type:
pdf
Category:
Communication To Health Care Professionals